Authors:
Portera, CA
Ho, V
Patel, SR
Hunt, KK
Feig, BW
Respondek, PM
Yasko, AW
Benjamin, RS
Pollock, RE
Pisters, PWT
Citation: Ca. Portera et al., Alveolar soft part sarcoma - Clinical course and patterns of metastasis in70 patients treated at a single institution, CANCER, 91(3), 2001, pp. 585-591
Citation: Bh. Zhang et al., Specific involvement of G(alpha i2) with epidermal growth factor receptor signaling in rat hepatocytes, and the inhibitory effect of chronic ethanol, BIOCH PHARM, 61(8), 2001, pp. 1021-1027
Citation: L. Pilote et al., Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995, CAN MED A J, 163(1), 2000, pp. 31-36
Citation: V. Ho et al., Multiple approaches to assessing the effects of delays for hip fracture patients in the United States and Canada, HEAL SERV R, 34(7), 2000, pp. 1499-1518
Authors:
Rubin, DL
Desser, TS
Semelka, R
Brown, J
Nghiem, HV
Stevens, WR
Bluemke, D
Nelson, R
Fultz, P
Reimer, P
Ho, V
Kristy, RM
Pierro, JA
Citation: Dl. Rubin et al., A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial, J MAGN R I, 9(2), 1999, pp. 240-250
Authors:
Clarke, AE
Petri, MA
Manzi, S
Isenberg, DA
Gordon, C
Senecal, JL
St Pierre, Y
Joseph, L
Penrod, J
Fortin, PR
Sutcliffe, N
Goulet, JR
Choquette, D
Grodzicky, T
Danoff, DS
Ho, V
Esdaile, JM
Citation: Ae. Clarke et al., An international perspective on the well being and health care costs for patients with systemic lupus erythematosus, J RHEUMATOL, 26(7), 1999, pp. 1500-1511